Clinical trial Recruiting at 1 site Observational Ages 18 to 90

See if hypotension during anesthesia induction relates to tissue oxygen in open-heart surgery

Official title: Investigation of the Relationship Between Hypotension and Tissue O2 in Invasive Eadyn During Anesthesia Induction in Open Heart Surgery: Observational Study

Run by Haseki Training and Research Hospital · NCT07831252 · Data updated 2026-11-12

This study tests whether post-induction hypotension in open-heart surgery patients can be predicted using arterial and tissue oxygenation measures.

Quick facts

Study typeObservational
Ages18 Years to 90 Years
SexAll
Enrollment40 (estimated)
SponsorHaseki Training and Research Hospital
Academic / other
Locations1 site (Istanbul, Sultangazi)
StatusRecruiting
StartedSeptember 1, 2025
Main results expectedDecember 17, 2026
Study endsDecember 17, 2026
Registry record updatedSeptember 21, 2026
Trial IDNCT07831252 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (ASA I–III) planned for open-heart surgery without the listed exclusions.

Probably not a fit

Patients with preexisting conditions or emergencies not represented in the cohort may not benefit from the findings.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study monitors adults undergoing open-heart surgery to see if post-induction hypotension correlates with tissue oxygenation in the brain and kidneys. Participants will be tracked from just before anesthesia through ten minutes after induction, with data on Eadyn, cerebral and renal regional saturation, and vasopressor responses collected. Patients will be grouped by the presence or absence of hypotension, and standardized monitoring will ensure consistent data capture. The aim is to understand how arterial load and tissue oxygenation interact during induction and whether this can help predict or prevent hypotension and related organ effects.

Why it matters

Potential benefit: If successful, findings could improve prediction and prevention of hypotension during anesthesia, potentially reducing organ injury risk.

How similar studies have gone: Previous research has explored predictors of post-induction hypotension, with novel measures like Eadyn showing promise, but this specific arterial-ventricular interaction in induction is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria: • American Society of Anaesthesiologists (ASA) Physical Status classification I to III

• Patients who planned open heart surgery

Exclusion Criteria: • Age \< 18 years

* Presence of arrhythmia (atrial fibrillation or frequent premature beats)
* Severe valvular heart disease (aortic or mitral stenosis/insufficiency)
* Severe heart failure (EF \< 40%)
* Congenital heart disease
* Severe chronic lung disease
* Chronic kidney disease requiring dialysis
* Severe peripheral vascular disease
* Morbid obesity
* Emergency surgery cases

Where it's running

  • Haseki Educational and Research Hospital
    Istanbul, Sultangazi, Turkey (Türkiye)
    Recruiting

Study contacts

  • Principal investigator: Muhammet A Gök, Medical Doctor — Haseki Educational and Research Hospital
  • Study coordinator: Muhammet A Gök, Medical Doctor
  • Email: drmuhammetaligook@gmail.com
  • Phone: +9005393824171

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.